HUMAW Humacyte, Inc.
$0.00▼ -78.05%
Healthcare
Other
Volume 258.7K
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.00 - 0.00
% vs 50 MA
-98.30%
% vs 200 MA
–%
RSI-14
41.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
-31.52
Free Cash Flow
-$22.17M
Gross Rev
$406,000
Gross Profit
-$825,000
EBITDA
-$24.82M
COGS
$1.23M
Operating Exp
$26.17M
Operating Income
-$27.00M
EBIT
-$27.00M
Pretax Income
-$36.80M
Net Income
-$36.80M
Price & Volume History
Loading chart…
Recent News
No recent news found for HUMAW.
Financial Overview - Income Statement
Quarterly
Jun 2026
See HUMAW's money flow as a full page
Social Sentiment
No Reddit posts found for HUMAW.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.